Quick answer
How much does Wegovy cost? As of September 2026, the manufacturer's self-pay price is $349 per month for the standard Wegovy pen ($399 for the HD pen), with new patients paying $199 per month for their first two fills, and $149 to $299 per month for the Wegovy pill depending on strength. trumprx.gov shows the same self-pay figures against an original price of $1,349 per month. With commercial insurance that covers Wegovy, the manufacturer's savings offer on wegovy.com, as of September 2026, says eligible patients "pay as little as $25" per month, capped at $100 of savings per month, and people on government insurance such as Medicare or Medicaid are excluded from that offer. Eligible Medicare Part D members can instead get Wegovy for a $50 copay through the federal Medicare GLP-1 Bridge, which runs from July 1, 2026 through December 31, 2027.
The Wegovy price ladder in one view
Think of Wegovy pricing as four rungs. The rules behind each are set by the manufacturer, your insurer, or the federal government, not by the pharmacy counter.
- Original (list) price: $1,349 per month for either the pen or the pill, as shown on trumprx.gov. It is the reference figure a pharmacy may quote before any discount, savings offer or self-pay program is applied.
- Self-pay offer: the manufacturer's cash price for people who pay without insurance. As of September 2026 it runs from $199 per month for the pen and from $149 per month for the pill, with the exact figure depending on the strength prescribed.
- Commercial insurance plus the savings offer: if your employer or marketplace plan covers Wegovy, the savings offer, as of September 2026, can bring your copay down to $25 per month, subject to a maximum of $100 in savings per month.
- Medicare GLP-1 Bridge: a $50 monthly copay for eligible Medicare Part D beneficiaries, from July 2026 through the end of 2027.
What is the list price of Wegovy?
The clearest published number comes from trumprx.gov, the federal government's drug-pricing site. Its comparison table, as of September 2026, lists "Wegovy Pen" at $199 per month and "Wegovy Pill" at $149 per month under "Lowest Presidential Deal," and shows an "Original Price" of $1,349 for both. The wegovy.com cost page does not print a list price; it presents the self-pay and insurance figures directly.
The list price matters if your plan does not cover Wegovy at all: the pharmacy may quote you something close to it unless you or the pharmacist apply the manufacturer's self-pay option described next. Which molecule the prescription names can matter as well, since our guide to Saxenda, Wegovy and the generic question notes that generic liraglutide pens for weight management are listed on DailyMed while semaglutide has none.
How much is Wegovy without insurance (self-pay)?
The manufacturer runs a cash program through NovoCare Pharmacy, and the same self-pay pricing can be processed at participating retail pharmacies. The terms page for that program says: "Patients must either be uninsured or have insurance (either commercial or government-funded), but decide to self-pay." In other words, the self-pay price is open to people with Medicare or Medicaid as long as they pay cash and do not bill their plan.
As of September 2026, the manufacturer's price tables work like this:
- Wegovy pen: new patients pay $199 per month for each of their first two monthly fills on the two lowest strengths. After that, the standard self-pay price, as of September 2026, is $349 per month across the regular strengths, and $399 per month for the higher-strength Wegovy HD pen. The introductory price applies to prescriptions written and received by the pharmacy by December 31, 2026.
- Wegovy pill: priced by strength, as of September 2026, from $149 per month for the lowest strength up to $299 per month for the two highest strengths. The manufacturer's page defines a month as one bottle of 30 tablets.
The terms carry restrictions worth reading before you count on the price. The program "cannot be combined with any other coupon, free trial, discount, prescription savings card, or other offer not associated with this offer." You must have a prescription for an FDA-approved use listed in the label, and you agree not to submit the purchase to any insurer. The manufacturer also states that "Novo Nordisk reserves the right to modify or cancel this program at any time."
A word on Wegovy coupon searches: the results are mostly pharmacy discount cards such as GoodRx, which apply to the pharmacy's retail price, and the manufacturer's own Wegovy savings card. The no-stacking clause quoted above means you choose one route at the counter, not a stack. If you fill at a retail pharmacy rather than NovoCare Pharmacy, Novo Nordisk's own page suggests asking the pharmacist three things before you pay: whether your insurance covers it and what your cost is before and after the deductible, whether you qualify for the savings card, and whether the pharmacy can process the self-pay option at your current strength. A fourth question belongs in that same conversation, whether the pharmacy actually has the presentation your prescription names on hand, and our guide to finding Wegovy in stock covers what to ask and what to do if the answer is no. The three prices can differ by hundreds of dollars for the same box, and the manufacturer's tables key on the strength and quantity fields explained in our guide to reading a prescription label.
What does Wegovy cost with commercial insurance?
If a commercial plan covers Wegovy, your cost is your plan's copay or coinsurance, and the manufacturer's savings offer sits on top of that. The offer's headline, in the manufacturer's words as of September 2026, is "pay as little as $25, subject to a maximum savings of $100/month." So a $125 plan copay becomes $25, while a $300 copay becomes $200. The card does not remove a deductible; it reduces what you owe after the plan processes the claim.
Three details from the enrollment page matter for real-world budgeting:
- It is not insurance, and it does not count toward your deductible. The manufacturer states: "The money spent and discounts on your prescription will not count toward your deductible or out-of-pocket requirements and cannot be submitted for reimbursement to your insurer."
- Government coverage disqualifies you, even if you also have a commercial plan. The page says: "Individuals with both commercial and government-funded plans ARE considered patients with government insurance." The examples listed are Medicare, Medigap, VA, DOD, TRICARE, and Medicaid.
- Some public-sector plans are treated as commercial. The same page notes that the Federal Employees Health Benefits Program, Affordable Care Act marketplace plans, and state employee plans are not considered government programs for the purposes of the offer.
The manufacturer defines a month as one box of four pens or one bottle of 30 tablets, and says eligibility and restrictions apply. You can enroll by texting the manufacturer's short code or through the NovoCare savings offer page.
What if my employer plan does not cover Wegovy?
An employer plan may not cover Wegovy at all, or may cover it only with prior authorization. Prior authorization means the plan will not pay until your prescriber submits a request showing you meet the plan's criteria. The federal Medicare GLP-1 Bridge works the same way: CMS says it uses "a single central processor to manage prior authorization, claims adjudication, and payment to pharmacies," and Novo Nordisk's page says your doctor "must submit a prior authorization request" for the $50 price.
If your plan simply does not cover it, the manufacturer's page suggests a different route: "Your healthcare professional can request coverage from your human resources (HR) department," and it offers a sample coverage letter to download. Employer coverage decisions are made at benefits renewal, so the letter is a long game; in the meantime, the self-pay price above is open to people who meet the manufacturer's eligibility terms and pay cash.
Does Medicare or Medicaid cover Wegovy?
Medicare. From July 1, 2026 through December 31, 2027, CMS is running a demonstration called the Medicare GLP-1 Bridge. In CMS's words: "Eligible beneficiaries will have a $50 copay. Eligible GLP-1 drugs furnished under the Medicare GLP-1 Bridge are provided outside of the Part D benefit payment flow and coverage." Because it sits outside the normal Part D flow, CMS notes that the Part D deductible does not apply, the $50 does not count toward your out-of-pocket total, and the low-income subsidy does not apply. Eligibility is set by CMS for Medicare Part D beneficiaries, and the manufacturer's page says your doctor must submit a prior authorization request and prescribe Wegovy for a medical use covered under the program. Medicare.gov/glp1bridge has the eligibility checker. For the older rules and how Part D treats obesity medications outside the demonstration, see our guide to Medicare coverage of Wegovy, Ozempic and other GLP-1 medications.
Medicaid. The manufacturer's savings offer excludes Medicaid enrollees, so the card is not an option. Medicaid members can still use the self-pay price if they pay cash and do not bill the plan. Whether your state's Medicaid program covers Wegovy under its own rules is a question for the plan itself; coverage terms are published by each state program, not by the manufacturer.
Can I use an HSA or FSA for Wegovy?
Generally yes, if it is prescribed to treat a diagnosed condition. IRS Publication 502 says: "You can include in medical expenses amounts you pay to lose weight if it is a treatment for a specific disease diagnosed by a physician (such as obesity, hypertension, or heart disease)." The same publication says you cannot include weight-loss costs when the purpose is appearance, general health, or a sense of well-being. Prescription drugs for a diagnosed condition are a qualified medical expense, so a Wegovy copay or self-pay payment can typically be paid with HSA or FSA funds. Keep the prescription and receipt. The mechanics, including reimbursing yourself later, are in the HSA and FSA guide for GLP-1 weight-loss medication.
How much does the Wegovy pill cost compared with the pen?
They are priced separately. Both forms sit on one FDA label; DailyMed lists the set as "WEGOVY- semaglutide injection, solution" and "WEGOVY- semaglutide tablet," indicated "in combination with a reduced calorie diet and increased physical activity." But the manufacturer prices them separately: as of September 2026 the self-pay pill runs from $149 to $299 per month by strength, while the pen is $199 per month for a new patient's first two fills and $349 to $399 after that. Under commercial insurance the savings offer's $25 floor and $100 cap apply to both, and under the Medicare GLP-1 Bridge the manufacturer's page says all strengths of both forms are $50 per month for eligible beneficiaries.
Why does the Wegovy price keep changing?
Because every rung of the ladder is set by a program that can be rewritten. The self-pay introductory price has an expiry date on its own terms page. The savings offer carries the line "Novo Nordisk reserves the right to modify or cancel this program at any time." The Medicare GLP-1 Bridge is a demonstration with an end date of December 31, 2027, and CMS's page says it "will be extended through December 31, 2027." The trumprx.gov figure is published under the heading "Lowest Presidential Deal," not as a fixed statutory price.
Before you fill, confirm the current figure on wegovy.com, novocare.com, or your plan's formulary page.
Where does compounded semaglutide fit?
Some pharmacies and telehealth companies sell compounded semaglutide at prices that differ from the manufacturer's, and you will see those offers when searching for Wegovy cost. They are not Wegovy. Compounded medications are not FDA-approved as final products. In the FDA's own words, "compounded drugs are not FDA approved. This means the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed." Whether a compounded product is appropriate is a decision for you and a prescribing physician, and price alone is not the basis for it. If you want the regulatory background, read is compounded semaglutide FDA approved?. For other FDA-approved options and how they compare on the label, see our Wegovy alternatives overview, and for the basics of the drug class, what is a GLP-1 medication?.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider. Compounded medications are not FDA-approved as final products. Medication is prescribed only if a licensed physician determines it is appropriate. Prices and program terms are the manufacturer's and the federal government's as published on September 19, 2026, and are subject to change.
Frequently Asked Questions
How much does Wegovy cost per month without insurance?
As of September 2026, the manufacturer's self-pay program prices the Wegovy pen from $199 per month for a new patient's first two fills and $349 to $399 per month after that, and the Wegovy pill from $149 to $299 per month depending on strength. The self-pay price is open to people who pay cash and do not bill a plan, including people with government insurance, as long as the prescription is for an FDA-approved use listed in the label and the program's other eligibility terms are met.
Do I have to order from NovoCare Pharmacy to get the Wegovy self-pay price?
No. The manufacturer runs the self-pay program through NovoCare Pharmacy, and participating retail pharmacies can process the same self-pay price. Novo Nordisk's cost page suggests asking the pharmacist whether they can apply the self-pay option at your current strength before you pay.
How does the Wegovy savings card work?
For people with commercial insurance that covers Wegovy, the manufacturer's offer, as of September 2026, reduces the copay to as little as $25 per month, with a maximum of $100 in savings per month. It is not insurance, does not count toward your deductible, and cannot be combined with other coupons or discount cards.
Can I use the Wegovy savings card if I have Medicare or Medicaid?
No. The manufacturer excludes anyone enrolled in a government-funded program, including Medicare, Medicaid, TRICARE, VA and Medigap, even if they also hold a commercial plan. Those patients can use the self-pay price or, for eligible Medicare Part D members, the $50 Medicare GLP-1 Bridge copay.
What is the Medicare GLP-1 Bridge?
It is a CMS demonstration running from July 1, 2026 through December 31, 2027 that gives eligible Medicare Part D beneficiaries access to certain GLP-1 drugs, including Wegovy, for a $50 copay. It requires prior authorization and operates outside the normal Part D benefit, so the deductible does not apply and the copay does not count toward out-of-pocket limits.
Is Wegovy an HSA or FSA eligible expense?
Generally yes when it is prescribed to treat a physician-diagnosed condition such as obesity. IRS Publication 502 allows weight-loss treatment costs in that situation and disallows them when the purpose is appearance or general well-being. Keep your prescription and receipts.
Can I combine a GoodRx coupon with the Wegovy self-pay price?
No. The manufacturer's self-pay terms state the offer "cannot be combined with any other coupon, free trial, discount, prescription savings card, or other offer not associated with this offer." A pharmacy discount card applies to the pharmacy's retail price instead, so get both quotes and use one.
Will the Wegovy price change again?
It can. The self-pay introductory price has an end date, the savings offer can be modified or canceled by the manufacturer at any time, and the Medicare GLP-1 Bridge is a time-limited demonstration. Confirm the current price on the manufacturer's site or with your plan before each fill.
Sources
This article is based on the following primary sources. Links open the original documents.
- 1.Wegovy: What Will I Pay? (cost and coverage page) · Novo Nordisk (wegovy.com) · accessed
- 2.Wegovy: What Will I Pay? (program modification clause) · Novo Nordisk (wegovy.com) · accessed
- 3.Wegovy: What Will I Pay? (employer coverage letter) · Novo Nordisk (wegovy.com) · accessed
- 4.NovoCare Pharmacy Terms and Conditions of Use (self-pay program eligibility and price tables) · Novo Nordisk (novocare.com) · accessed
- 5.NovoCare Pharmacy Terms and Conditions of Use (no stacking clause) · Novo Nordisk (novocare.com) · accessed
- 6.Wegovy Savings Offer enrollment page (government insurance definition) · Novo Nordisk (novocare.com) · accessed
- 7.Wegovy Savings Offer enrollment page (deductible clause) · Novo Nordisk (novocare.com) · accessed
- 8.TrumpRx price comparison (Wegovy pen and pill listing) · U.S. Government (trumprx.gov) · accessed
- 9.Medicare GLP-1 Bridge · Centers for Medicare & Medicaid Services · accessed
- 10.Medicare GLP-1 Bridge (prior authorization) · Centers for Medicare & Medicaid Services · accessed
- 11.Medicare GLP-1 Bridge (extension) · Centers for Medicare & Medicaid Services · accessed
- 12.IRS Publication 502, Medical and Dental Expenses (Weight-Loss Program) · Internal Revenue Service · accessed
- 13.DailyMed: WEGOVY (semaglutide) injection and tablet label · U.S. National Library of Medicine, DailyMed · accessed
- 14.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · U.S. Food and Drug Administration · accessed
Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.
- Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
- Documented compliance review against FDA, FTC and LegitScript requirements before publication
- External sources, where an article cites them, are listed at the end of that article with links to the original documents
- Compounded medications are described as not FDA-approved as final products on every page that mentions them